美国感染新冠病毒住院的年轻成年人的临床结局
Clinical Outcomes in Young US Adults Hospitalized With COVID-19.
作者信息
Cunningham Jonathan W, Vaduganathan Muthiah, Claggett Brian L, Jering Karola S, Bhatt Ankeet S, Rosenthal Ning, Solomon Scott D
机构信息
Brigham and Women's Hospital, Boston, Massachusetts.
Premier Applied Sciences, Premier Inc, Charlotte, North Carolina.
出版信息
JAMA Intern Med. 2020 Sep 9;181(3):379-81. doi: 10.1001/jamainternmed.2020.5313.
Abstract
This case series examines the clinical outcomes for young adults hospitalized with COVID-19.
摘要
本病例系列研究了因新冠肺炎住院的年轻人的临床结局。
相似文献
1
Clinical Outcomes in Young US Adults Hospitalized With COVID-19.
JAMA Intern Med. 2020 Sep 9;181(3):379-81. doi: 10.1001/jamainternmed.2020.5313.
2
Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
Ann Intern Med. 2021 Oct;174(10):1409-1419. doi: 10.7326/M21-1991. Epub 2021 Aug 10.
3
Children, adolescents, and young adults hospitalized with COVID-19 and diabetes in summer 2021.
Pediatr Diabetes. 2022 Nov;23(7):961-967. doi: 10.1111/pedi.13396. Epub 2022 Aug 5.
4
Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US.
Front Pediatr. 2023 Sep 11;11:1261046. doi: 10.3389/fped.2023.1261046. eCollection 2023.
5
Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021-September 2022.
Open Forum Infect Dis. 2023 Dec 30;11(1):ofad702. doi: 10.1093/ofid/ofad702. eCollection 2024 Jan.
6
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.
7
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
JAMA Netw Open. 2021 Jul 1;4(7):e2116901. doi: 10.1001/jamanetworkopen.2021.16901.
8
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Outcomes of COVID-19 adults managed in an outpatient versus hospital setting.
PLoS One. 2022 Feb 14;17(2):e0263813. doi: 10.1371/journal.pone.0263813. eCollection 2022.
引用本文的文献
1
Outcomes and Resource Utilization in Hyperkalemic Emergency Department Patients Treated With Patiromer or Sodium Zirconium Cyclosilicate.
J Am Coll Emerg Physicians Open. 2025 May 10;6(4):100158. doi: 10.1016/j.acepjo.2025.100158. eCollection 2025 Aug.
2
New Kids on the Block: Estimating Use of Next-generation Gram-negative Antibiotics Across Greater Than 700 Hospitals in the United States.
Open Forum Infect Dis. 2025 Feb 12;12(2):ofaf079. doi: 10.1093/ofid/ofaf079. eCollection 2025 Feb.
3
Characteristics associated with high hospital spending over 1 year among patients hospitalised for COVID-19 in the USA: a cohort study.
BMJ Public Health. 2023 Nov 7;1(1):e000263. doi: 10.1136/bmjph-2023-000263. eCollection 2023 Nov.
4
The burden of COVID-19 in primary care of Almaty, Kazakhstan, 2021-2022.
Sci Rep. 2025 Feb 12;15(1):5186. doi: 10.1038/s41598-025-89707-5.
5
Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study.
Open Forum Infect Dis. 2025 Jan 10;12(2):ofaf013. doi: 10.1093/ofid/ofaf013. eCollection 2025 Feb.
6
Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review.
Viruses. 2024 Oct 30;16(11):1694. doi: 10.3390/v16111694.
7
Hospital outcomes for young adults with COVID-19.
Glob Epidemiol. 2024 Jul 5;8:100155. doi: 10.1016/j.gloepi.2024.100155. eCollection 2024 Dec.
8
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
9
Multi-Organ Systems Involvement in COVID-19 is Associated With a Worse Prognosis.
J Acute Med. 2024 Jun 1;14(2):61-73. doi: 10.6705/j.jacme.202406_14(2).0002.
10
Finding Silver Linings: A Mixed Methods Analysis of COVID-19's Challenges and Opportunities for College Students' Functioning and Outlook.
Emerg Adulthood. 2022 Apr;10(2):491-510. doi: 10.1177/21676968211060946.
本文引用的文献
1
SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region.
JAMA. 2020 Jul 28;324(4):392-395. doi: 10.1001/jama.2020.11374.
2
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.
3
Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.
Am J Med. 2020 May;133(5):605-612.e1. doi: 10.1016/j.amjmed.2019.10.020. Epub 2019 Nov 9.
4
Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
JAMA. 2017 Apr 11;317(14):1433-1442. doi: 10.1001/jama.2017.2841.
Zotero 插件